ADHANSIA Trademark

Trademark Overview


On Monday, May 8, 2017, a trademark application was filed for ADHANSIA with the United States Patent and Trademark Office. The USPTO has given the ADHANSIA trademark a serial number of 87440283. The federal status of this trademark filing is REGISTERED as of Tuesday, December 1, 2020. This trademark is owned by Purdue Pharma. The ADHANSIA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis

Providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system
adhansia

General Information


Serial Number87440283
Word MarkADHANSIA
Filing DateMonday, May 8, 2017
Status700 - REGISTERED
Status DateTuesday, December 1, 2020
Registration Number6208234
Registration DateTuesday, December 1, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis
Goods and ServicesProviding health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system
Translation of Words in MarkThe wording "ADHANSIA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 11, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 11, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePURDUE PHARMA L.P.
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressSTAMFORD, CT 06901

Party NamePURDUE PHARMA L.P.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressSTAMFORD, CT 06901

Party NamePURDUE PHARMA L.P.
Party Type11 - New Owner Before Publication
Legal Entity Type13 - Limited Partnership
AddressSTAMFORD, CT 06901

Party NamePurdue Pharma
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressPickering, Ontario L1W3W8
CA

Trademark Events


Event DateEvent Description
Tuesday, December 1, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, October 27, 20201(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, October 9, 2020NOTICE OF ALLOWANCE CANCELLED
Friday, October 9, 2020TEAS DELETE 1(B) BASIS RECEIVED
Thursday, October 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 25, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 25, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 22, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 8, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 8, 2019INQUIRY TO SUSPENSION E-MAILED
Thursday, August 8, 2019SUSPENSION INQUIRY WRITTEN
Wednesday, February 20, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 13, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 13, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 8, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 8, 2019LETTER OF SUSPENSION E-MAILED
Friday, February 8, 2019SUSPENSION LETTER WRITTEN
Thursday, January 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 17, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 16, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 18, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, July 18, 2018INQUIRY TO SUSPENSION E-MAILED
Wednesday, July 18, 2018SUSPENSION INQUIRY WRITTEN
Friday, July 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 13, 2018ASSIGNED TO LIE
Friday, June 29, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, February 3, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, February 3, 2018LETTER OF SUSPENSION E-MAILED
Saturday, February 3, 2018SUSPENSION LETTER WRITTEN
Tuesday, January 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 5, 2017NON-FINAL ACTION E-MAILED
Saturday, August 5, 2017NON-FINAL ACTION WRITTEN
Friday, August 4, 2017ASSIGNED TO EXAMINER
Thursday, May 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 11, 2017NEW APPLICATION ENTERED IN TRAM